News & Updates

Patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC) with good ECOG* performance status and radioactive iodine (RAI) avidity benefit the most from treatment with lenvatinib, a study has shown. Moreover, the only independent predictor of survival after treatment initiation is objective response.

Some childhood cancer survivors (CCS) may experience psychological distress and have low health-related quality of life (HRQOL) after completing their cancer treatments, suggests a Singapore study.

In postmenopausal women, breast adiposity appears to influence various adverse body composition and metabolic factors, suggests a study.

A secondary analysis of the ASPREE* and ALSOP** studies found an association between a Mediterranean Diet (MedDiet) pattern and reduced risks of cardiometabolic conditions and frailty in older Australian adults.

Older nursing home residents who have been deprescribed antihypertensive medications show slower cognitive decline when compared with residents who maintain a stable antihypertensive regimen, as shown in a study.

The investigational antidepressant mirtazapine appears no better than placebo at alleviating severe, intractable breathlessness from chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD), as shown in the phase III BETTER-B trial.

In stable post-MI patients without a reduced EF who have been on long-term β-blockers, interrupting the β-blocker treatment instead of continuing it leads to more hospitalizations for CV reasons and does not improve QoL, as shown in the phase III ABYSS trial presented at ESC 2024

Prediabetes in adolescent or young adult females has been linked to increased likelihood of gestational diabetes and adverse maternal and neonatal outcomes at first birth in a recent retrospective cohort study.